Evidence supporting the use of: Astaxanthin
For the health condition: Dementia

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Astaxanthin is a naturally occurring carotenoid found in microalgae, yeast, salmon, trout, and krill. Its use for dementia is primarily based on its potent antioxidant and anti-inflammatory properties, which have been hypothesized to protect neuronal cells from oxidative stress—a key factor implicated in neurodegenerative diseases like Alzheimer’s and other forms of dementia. Several preclinical studies demonstrate that astaxanthin can cross the blood-brain barrier, reduce oxidative damage, and modulate inflammatory pathways in animal models of neurodegeneration.

Human evidence, however, is limited. A small number of preliminary clinical trials have explored astaxanthin’s effects on cognitive function in older adults. For example, a randomized controlled trial published in Journal of Clinical Biochemistry and Nutrition (2018) found that astaxanthin supplementation for 12 weeks resulted in mild improvements in memory and cognitive performance in middle-aged and elderly subjects with mild cognitive complaints. Nonetheless, these studies are small, short-term, and often lack robust dementia diagnoses as inclusion criteria. Major clinical trials specifically targeting diagnosed dementia patients are lacking.

In summary, while there is a scientific rationale and some early evidence suggesting a potential neuroprotective role for astaxanthin, the current human evidence is weak and insufficient for definitive recommendations. Its use is not based on traditional medicine, but rather on emerging scientific interest in its antioxidant effects. Larger, long-term clinical trials are needed to clarify its efficacy in dementia treatment or prevention.

More about astaxanthin
More about Dementia